Background: Corticolimbic circuits, including direct projections from prefrontal cortex to nucleus accumbens (NAc), permit top-down control of intense motivations generated by subcortical circuits. In rats, localized disruptions of glutamate signaling within medial shell of NAc generate desire or dread, anatomically organized along a rostrocaudal gradient analogous to a limbic keyboard. At rostral locations in shell, these disruptions generate appetitive eating, but at caudal locations the disruptions generate progressively fearful behaviors (distress vocalizations, escape attempts, and antipredator reactions). Here, we asked whether medial prefrontal cortex can modulate intense motivations generated by subcortical NAc disruptions.
M otivations or emotions generated by subcortical circuits involving the nucleus accumbens (NAc) may be powerfully modulated by top-down corticolimbic controls from prefrontal cortex (1, 2) . In humans, successful voluntary suppression of subjective cravings or emotional responses is accompanied by activation of prefrontal cortical areas and simultaneous reduction of subcortical activity in NAc, amygdala, and ventral tegmentum (1, (3) (4) (5) (6) .
Here, we sought to probe corticolimbic modulation of intense unconditioned appetitive and defensive behaviors generated by disruptions in medial shell of NAc in the rat. The medial shell of NAc is an important node in the generation of both positive desire and aversive dread (7) (8) (9) (10) (11) (12) (13) . Localized disruptions of glutamate transmission in medial shell, via microinjections of the a-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) antagonist 6,7-dinotroquinoxaline-2,3(1H,4H)-dione (DNQX), generate intense unconditioned appetitive and/or fearful behaviors organized along a rostrocaudal gradient (probably involving disinhibition of ventral pallidum, hypothalamus, and related targets from gamma-aminobutyric acid [GABA]ergic suppression, thus releasing motivation-generating circuits) (14) (15) (16) (17) (18) . Rostral disruptions in NAc shell evoke purely appetitive behaviors like voracious eating (19, 20) . Caudal disruptions instead evoke increasingly fearful behaviors, including audible distress vocalizations, escape attempts, and spontaneous defensive treading, an innate antipredator reaction in which rodents toss debris at a threatening stimulus (e.g., rattlesnake) (21) (22) (23) (24) (25) (26) . Intermediate disruptions produce ambivalent mixtures of appetitive and fearful behaviors (27, 28) .
The valence of motivation produced by glutamate disruption at many shell sites can be retuned by changes in external ambience, which might reflect top-down influences from cortex and related structures that send glutamate inputs to NAc (27, 28) . This study probed three regions of prefrontal cortex that send direct glutamate projections to the medial shell. First, the medial orbitofrontal cortex (Brodmann area 10) ( [29, 30] , but see [31] ) is implicated in pleasure and emotion (32, 33) . Second, the infralimbic cortex (34) is homologous to human subgenual or deeply ventral anterior cingulate cortex (Brodmann area 25) (35) (36) (37) and has been suggested to suppress motivated behaviors, such as reinstatement of cocaine and food seeking (38, 39) and conditioned fear (40) . Third, the prelimbic cortex (potentially homologous to Brodmann areas 24 and 32 of anterior cingulate cortex) (35) (36) (37) projects to NAc shell and core and has been suggested to participate in appetitive and fearful motivations (41) (42) (43) and in some forms of inhibitory control (44, 45 ). Here, we tested the effects of reversible activation versus inhibition of medial orbitofrontal, infralimbic, and prelimbic cortex on the ability of glutamate disruptions within NAc shell to produce unconditioned appetitive and fearful motivated behaviors.
Methods and Materials

Experimental Design
To investigate whether activity in infralimbic, prelimbic, and orbitofrontal regions of medial prefrontal cortex modulates the generation of strong unconditioned motivations by NAc shell glutamate disruptions, we simultaneously generated eating or fearful defensive behaviors via microinjections in medial shell of a low dose of the AMPA antagonist DNQX (250 ng/.2 mL per side in 50% saline/50% dimethyl sulfoxide), while temporarily either activating or inhibiting each prefrontal region ( Figure 1A ). Temporary activation of prefrontal cortex was produced by microinjections of the GABA type A antagonist bicuculline (.1 mg/.2 mL per side in artificial cerebrospinal fluid), which by preventing local inhibition induces relative activation of neurons (46) . Using bicuculline allowed receptor-based comparison with the opposite polarity effects of GABA agonist microinjections at the same prefrontal sites (muscimol/baclofen microinjections). We conducted a careful slow motion video analysis of behavior to ensure that no seizure indicators were ever produced by bicuculline in prefrontal cortex, which is consistent with previous reports of no seizure manifestations after bicuculline injected into cortex at doses similar to ours or even higher (47) (48) (49) (50) (51) (52) . Temporary inhibition of cortex was produced by a mixture of GABA type A and GABA type B agonists, muscimol (5 ng per side) and baclofen (65 ng per side in .2 mL artificial cerebrospinal fluid) (38) . Microinjection spread was assessed by Fos plumes surrounding drug microinjections. We have previously found that the diameter of drug-induced Fos plumes shrinks after several microinjections (28) , and therefore we used a dedicated Fos group measured after a single microinjection to capture maximal diameter.
Subjects
Male Sprague-Dawley rats (n ¼ 124; prefrontal activation, n ¼ 68; prefrontal inhibition, n ¼ 30; Fos analysis, n ¼ 26; 300 Figure 1 . Microinjection conditions and DNQX effects. Rats received the following microinjections (A): rats in the activation group (top, n ¼ 68) received either DNQX or vehicle in nucleus accumbens (NAc) shell and bicuculline or vehicle into prefrontal cortex, and rats in the inactivation group (bottom, n ¼ 30) received either DNQX or vehicle in NAc shell and a baclofen plus muscimol combination or vehicle in prefrontal cortex. Fos plume maps show the effects of DNQX alone (vehicle in prefrontal cortex) on eating (B) (green) or defensive treading behavior (C) (red). Histogram bars above the maps show mean behaviors as a percent of vehicle at each rostrocaudal level (errors bars ¼ SEM; the n at each level is listed in the bar). Summary bar graphs show the DNQX induced eating (B) and treading (C) as change from vehicle at rostral (n ¼ 26), middle (n ¼ 30), and caudal (n ¼ to 400 g before surgery) were housed at $ 211C on a reverse 12:12 light:dark cycle, with ad libitum access to both food and water. All experiments were approved by the University Committee on the Use and Care of Animals at the University of Michigan.
Surgery and Drug Microinjections
Rats received bilateral implantation of cranial cannulae aimed at points throughout the rostrocaudal extent of medial shell of NAc and a separate pair aimed at either the infralimbic, prelimbic, or medial orbitofrontal regions of prefrontal cortex. Following 1 week of recovery, each rat (n ¼ 68; infralimbic, n ¼ 26; prelimbic, n ¼ 11; orbitofrontal, n ¼ 29) in the prefrontal activation group was tested after the following four drug conditions for spontaneous motivated behavior (see Supplement 1 for more detail): 1) vehicle in prefrontal cortex and vehicle in NAc; 2) bicuculline in prefrontal cortex and vehicle in NAc; 3) vehicle in prefrontal cortex and DNQX in NAc; and 4) bicuculline in prefrontal cortex and DNQX in NAc. Each rat in the prefrontal inhibition group (n ¼ 30; infralimbic, n ¼ 9; prelimbic, n ¼ 5; orbitofrontal, n ¼ 16) received the following four drug conditions: 1) vehicle in prefrontal cortex and vehicle in NAc; 2) baclofen plus muscimol in prefrontal cortex and vehicle in NAc; 3) vehicle in prefrontal cortex and DNQX in NAc; and 4) baclofen plus muscimol in prefrontal cortex and DNQX in NAc ( Figure 1A ). Each rat in the Fos group received comparable single microinjections of one above condition.
Behavioral Coding
Observers blind to drug treatment scored each 60-minute session for the total time (seconds) spent in each of the following behaviors: appetitive behaviors such as eating (mouth on the food or engaged in chewing action) and drinking (licking the spout of the water bottle), fearful behavior consisting of defensive treading (spraying or pushing of bedding by rapid alternating thrusts of the forepaws), and grooming (a stereotyped sequence described in [53] ). Observers scored the total number for behaviors that tended to occur as discrete events, including appetitive behaviors such as food carrying (transportation of food pellets in the mouth) and food sniffs (sniffing near the food for at least 1 s), and two general motor activities: rearing (forepaws at least 1 in. off the floor) and cage crosses (forepaws and head cross the halfway point of the cage). Observers also looked for any indicators of seizure, including behavioral arrest or akinesia (freezing) and stereotyped behaviors including repetitive blinking or rhythmic jaw opening, head nodding, head shaking, wet dog shakes (repetitive shaking of the entire trunk), tonic seizures (sudden-onset tonic extension or flexion of the head, trunk, and/or extremities for several seconds), sudden loss of posture (falling over), and myoclonic or clonic twitches (brief arrhythmic or rhythmic jerking of a muscle group).
Fos-like Protein Immunohistochemistry
Rats used for Fos analysis (n ¼ 26) were anesthetized with an overdose of sodium pentobarbital and transcardially perfused 90 min after bilateral microinjection of either 1) vehicle in prefrontal cortex and vehicle in NAc (n ¼ 6), 2) bicuculline in prefrontal cortex and vehicle in NAc (n ¼ 2), 3) vehicle in prefrontal cortex and DNQX in NAc (n ¼ 8), or 4) bicuculline in prefrontal cortex and DNQX in NAc (n ¼ 4) for Fos plumes analysis, and 5) vehicle in prefrontal cortex and no injection in NAc (n ¼ 3), or 6) bicuculline in prefrontal cortex and no injection in NAc (n ¼ 3) for analysis of the effect of prefrontal activation on baseline NAc Fos (see Supplement 1 for more detail).
Results
Local Glutamate Disruptions in Medial Shell of NAc Induce Appetitive and Defensive Behavior Organized Along a Rostrocaudal Gradient
When prefrontal cortex received no drug manipulation (vehicle microinjection), localized glutamate disruptions in medial shell generated intense appetitive eating and/or fearful behaviors as expected, organized by valence along the usual rostrocaudal gradient ( Figure 1B ). Medial shell microinjections of a moderate dose of DNQX produced robust stimulation of eating and food consumption to above five times vehicle control levels, with the most intense eating (of up to 10 g) occurring from the most rostral sites [ Figure 1B; Figure 1C ; average of 31.3 s Ϯ 6.13 SEM after caudal DNQX vs. .49 s on vehicle control; drug Â placement, F(1,74) ¼ 9.550, p r .001].
Medial Orbitofrontal Activation Specifically Enhances Appetitive Motivation Produced by NAc Shell
Co-activation of medial orbitofrontal cortex (immediately rostral to infralimbic cortex) selectively enhanced eating induced by NAc DNQX at middle and caudal sites that otherwise produced only fear (Figures 2A and 3A) . Orbitofrontal activation made caudal DNQX generate levels of eating that were 250% of levels without orbitofrontal activation and as high as any eating generated at rostral DNQX sites [up to 9.5 g; eating time: Figure 3A ]. At more rostral NAc sites for DNQX, which generated high levels of food intake to begin with (45 times control), robust eating remained unchanged by orbitofrontal co-activation ( Figure 3A 
Infralimbic Suppression Is Specific to DNQX-Induced Levels of Motivation
Infralimbic cortex activation did not interfere with baseline levels of spontaneous appetitive and defensive behaviors after vehicle microinjection in NAc. Infralimbic microinjections of bicuculline did not suppress moderate baseline levels of eating or drinking (Fs o 1; Figure 3C ), nor change baseline defensive behaviors, which remained near zero ( Figure 3D; 
Prelimbic Activation Has No Effect on Motivated Behaviors Generated by NAc Shell DNQX
By contrast to co-activation of infralimbic cortex, which suppressed DNQX appetitive and fearful behaviors, co-activation of the immediately dorsal region of prelimbic cortex failed to alter NAc DNQX-induced eating or food intake [ Figure 2A ; eating time:
. Prelimbic cortex co-activation also failed to alter defensive treading behavior, distress calls, or escape attempts induced by glutamate disruptions in NAc caudal shell ( Figure 2B ; prelimbic cortex: defensive treading, Fs o 1). Finally, co-activation of prefrontal cortex had no impact on baseline defensive behaviors in the absence of NAc DNQX, which remained near zero (defensive treading, F o 1, McNemar's Test, vocalizations and escape attempts, p ¼ 1.00).
No behavioral indicators of seizure were observed after microinjections of bicuculline in either prelimbic, infralimbic, or . Motivated behavior graphs. Graphs demonstrating the specific effects of medial orbitofrontal activation (left) and infralimbic activation (right) on appetitive eating (top) and defensive treading (bottom), depending on particular rostrocaudal location (rostral, middle, or caudal). Simultaneous microinjections of bicuculline in medial orbitofrontal (n ¼ 29) with DNQX in nucleus accumbens (NAc) shell (black, left) produced enhancement of DNQX induced eating (A) (green), specifically at more middle (n ¼ 11) and caudal (n ¼ 7) locations but not rostral (n ¼ 11) and had no effect on DNQX-induced treading (B) (red). Microinjections of bicuculline in infralimbic cortex (n ¼ 26) with simultaneous DNQX in NAc shell (black, right) produced suppression of both DNQX-induced eating (C) (green) from rostral sites (n ¼ 12) and treading (D) (red) from caudal sites (n ¼ 7; middle sites, n ¼ 7 
Fos Plume Analysis: Determining Functional Microinjection Drug Spread
We assessed Fos plumes produced by DNQX microinjections in NAc and bicuculline microinjections in orbitofrontal and infralimbic prefrontal cortex and also assessed whether prefrontal bicuculline modulated distant Fos plumes in NAc induced by DNQX in medial shell ( Figure 5 ). Microinjections of DNQX in NAc shell produced plumes containing a small .008 mm 3 volume center where Fos expression was more than doubled (radius ¼ .125 mm), surrounded by a larger .056 mm 3 sphere of mildly elevated Fos expression between 1.5 to 2 times vehicle levels (radius ¼ .24 mm; Figure 5B Prefrontal inhibition has no effect on DNQX eating (% DNQX)
Prefrontal inhibition has no effect on DNQX treading (% DNQX) 
Discussion Medial Orbitofrontal Amplification of Subcortically Generated Eating
We found that activation of medial orbitofrontal cortex biased the valence of motivation generated by NAc DNQX in an appetitive direction. Activation of medial orbitofrontal neurons by bicuculline microinjection specifically enhanced the eating generated by microinjections in caudal NAc shell, which otherwise produced mostly fearful behaviors. The intensity of eating generated at caudal NAc sites rose to levels equaling those normally produced by DNQX microinjections at more rostral sites, which produced almost purely appetitive valence. However, orbitofrontal activation never generated behavior on its own, nor further enhanced the already intense eating generated by DNQX in rostral NAc. That pattern suggests that orbitofrontal cortex specifically modulates intense eating generated by NAc, up to the level of a response ceiling. Alternatively, it is possible that orbitofrontal co-activation can enhance positive valence only in the presence of a pre-existing state of negatively valenced fear or anxiety.
In human studies of sensory rewards, neuroimaging activation of a specific mid-anterior region of orbitofrontal cortex (32) is specifically associated with subjective pleasure for food, as well as drugs, music, etc. (32, (54) (55) (56) (57) (58) . A special role for orbitofrontal cortex in coding human pleasure seems consistent with our finding that orbitofrontal activation specifically enhanced positive incentive motivation generated by some sites of NAc (32, 59) .
Infralimbic Cortex Suppresses Subcortically Generated Fear and Eating
We found that activation of infralimbic cortex (corresponding in humans to deeply ventral or subgenual anterior cingulate cortex; area 25) generally inhibited the intensity of both positive and negative motivations produced by glutamate disruptions in NAc shell. Thus, infralimbic activation acted primarily as a nonspecific brake, suppressing appetitive behavior elicited by disruption at rostral shell sites and suppressing fearful behaviors elicited at caudal shell sites. Our findings therefore support the hypothesis that infralimbic cortex activation might generally regulate or inhibit the subcortical generation of intense motivations of either positive or negative valence.
This hypothesis may fit with neuroimaging evidence from humans. For instance, anterior cingulate cortex is activated when people successfully engage in voluntary efforts to suppress their Figure 6 . Potential mechanisms of prefrontal modulation of DNQX generated motivated behaviors. Proposed direct prefrontal to nucleus accumbens (NAc) shell mechanism (A) mediating opposite infralimbic vs. orbitofrontal effects on DNQX-induced eating. Bicuculline infusions excite glutamate inputs (green) from infralimbic or medial orbitofrontal cortex. DNQX alone inhibits rostral NAc shell projection neurons (red), resulting in disinhibition of downstream targets and intense eating. Infralimbic activation may overcome DNQX inhibition of these same neurons, suppressing eating. Medial orbitofrontal activation may instead activate gamma-aminobutyric acid (GABA)ergic interneurons, which further inhibit neurons already inhibited by DNQX, potentiating eating. A circuit diagram (B) shows prefrontal and NAc shell projections to relevant third-party structures that may mediate larger circuit interactions. DNQX microinjections likely inhibit neurons in NAc shell, disinhibiting downstream structures such as ventral pallidum, lateral hypothalamus, and ventral tegmental area (yellow) via GABAergic projections neurons (red). Medial orbitofrontal and infralimbic activation may act to modulate DNQX-induced behaviors via direct glutamate (green) projections to NAc shell or parallel projections to structures such as medial dorsal hypothalamus, lateral hypothalamus, and basolateral amygdala.
aversive emotional reactions to distressing photos or to suppress their appetitive cravings to images of palatable foods, and those anterior cingulate activations are accompanied by reductions of activity in NAc, ventral tegmental area, and extended amygdala otherwise triggered by viewing the same images (4, 5) . Infralimbic suppression of subcortically generated motivation is also consistent with findings in rodent studies that infralimbic cortex suppresses reinstated seeking of cocaine and food rewards (38, 39, (60) (61) (62) and similarly suppresses reinstatement of conditioned fear responses (41, 43, 63) . Our findings extend infralimbic suppression to include intense unconditioned appetitive and fearful behaviors, which do not depend on learning or explicitly require top-down control to be generated.
Prefrontal Cortical Excitation Modulates but Is Not Necessary for Enhanced Motivation
Our results also showed an asymmetrical role of cortical excitation versus inhibition in modulating motivations generated by inhibition of NAc shell. Excitation of medial orbitofrontal and infralimbic cortex modulated motivations released by NAc shell DNQX microinjections as described above, but inhibition of the same orbitofrontal or infralimbic cortex regions failed to alter NAc shell desire or dread in any detectable way. This asymmetrical pattern suggests that unconditioned motivations elicited by NAc shell disruptions may not need input from prefrontal cortex but that supranormal levels of prefrontal activation are nonetheless able to modulate these motivations. Additionally, our finding that neither prefrontal excitation nor inhibition affected normal levels of baseline eating and fearful behavior may indicate that normal levels of unconditioned eating and fear do not require prefrontal control.
Overall, our results are consistent with the notion that infralimbic cortex and orbitofrontal cortex hierarchically control NAc production of intense desire and dread (64) . Prefrontal cortex acted here as hierarchically superior in the functional sense of being able to suppress and/or modulate the valence of robust motivations triggered by disruptions of NAc. At the same time, while subordinate, the NAc still possessed a degree of autonomy that is characteristic of a hierarchical element. That is, only manipulations of NAc and not prefrontal cortex were capable of producing intense levels of motivated behaviors. Such features of suppression/modulation by a hierarchically superior unit, combined with semiautonomy of a subordinate unit, have been suggested to characterize functional hierarchies (64) .
Neurobiological Bases of Infralimbic Versus Orbitofrontal Top-Down Regulation
Local AMPA blockade by DNQX likely produces relative hyperpolarizations in NAc neurons by reducing glutamatergic depolarizations (65) . This likely reduces firing and GABA release by NAc projection neurons and thus disinhibits downstream target neurons in ventral pallidum, lateral hypothalamus, and ventral tegmentum to generate intense levels of motivated behaviors (14) (15) (16) (17) (18) .
How does prefrontal cortex activation interact with NAc release of intense motivations? There may be a relatively straightforward explanation for the effects of infralimbic cortex activation, which directly opposed or suppressed NAc DNQXinduced motivation. If infralimbic activation increases glutamate release on NAc neurons that are hyperpolarized by DNQX, that elevated glutamate level may compete with and perhaps partially overcome the local hyperpolarization, thus reducing the intensity of DNQX-elicited motivations. The explanation of orbitofrontal modulation of NAc DNQX-generated eating is probably more complex. One possibility is that orbitofrontal activation may inhibit some NAc shell neurons by activation of inhibitory GABAergic interneurons. Nucleus accumbens shell neurons are reported to be excited by either orbitofrontal activation or infralimbic activation, but not both (66) . That is, if a particular NAc neuron is excited by infralimbic cortex, it may be inhibited by medial orbitofrontal cortex (66) . Conversely, if a NAc neuron is excited by orbitofrontal cortex, it is inhibited by infralimbic cortex. This mutual exclusivity suggests two parallel corticolimbic channels, with mutual inhibition between them. Thus, orbitofrontal activation may inhibit some NAc shell neurons (specifically those excited by infralimbic activation). If inhibition of these NAc shell neurons contributes to intense appetitive behaviors, then orbitofrontal activation may increase the intensity of eating by augmenting their hyperpolarization ( Figure 6A ). If this hypothesis is correct, then future pharmacologic or optogenetic inactivation of local interneurons might modulate orbitofrontal-NAc interactions in producing intense motivated behaviors.
A second category of explanation for infralimbic or medial orbitofrontal effects goes beyond direct projections to involve indirect modulations via wider mesocorticolimbic networks, whereby prefrontal activations could recruit third-party structures to modulate the valence or intensity of intense motivations produced by NAc inhibition (including brain structures such as basolateral amygdala, lateral and medial dorsal hypothalamus, or brainstem) ( Figure 6B ) (30, (67) (68) (69) (70) . Combined manipulations of these other subcortical structures could be used in the future to test their roles in modulating prefrontal-NAc shell interactions.
Clinical Implications
Improved top-down control could help deal with maladaptively intense emotions in a variety of psychopathologies involving corticolimbic circuitry, including addiction, schizophrenia, and posttraumatic stress disorder (71) (72) (73) (74) . Speculatively, treatments aimed at enhancing medial orbitofrontal function might conceivably help increase positively valenced emotion or shift the balance away from negatively valenced emotions. Reduced orbitofrontal volume is found in patients with schizophrenia, panic disorders, posttraumatic stress disorder, and obsessivecompulsive disorder (75) (76) (77) (78) (79) . Extrapolation of our results to such conditions would suggest that enhancing orbitofrontal activity might help add to positive appetitive motivation in cases where intense but negative valenced emotion already exists, such as in pathological anxiety or fearful paranoia.
In contrast, reduced activity in subgenual anterior cingulate cortex (homologous to infralimbic cortex in our study) has been reported to leave some patients with reduced ability to regulate certain unwanted emotions, such as in posttraumatic stress disorder (80) . Additionally, abnormalities in area 25 in cocaine addicts are associated with reduced top-down control and poor decision making (81) . Again, speculatively applying our findings, these results support the view that activation of deep anterior cingulate area 25, homologous to infralimbic cortex here, might suppress the levels of unwanted intense emotions, regardless of whether the valence of the pathological emotion was appetitive or fearful.
In conclusion, our results suggest orbitofrontal cortex may play an important role in enhancing the positive valence of intense emotional states that might otherwise be purely fearful or anxious. Additionally, deep anterior cingulate or infralimbic cortex may be important in suppressing intense emotional states involving either desire or dread. These demonstrations of topdown hierarchical control over intense motivations generated by subcortical neural events in nucleus accumbens illustrate corticolimbic mechanisms that may contribute to regulating normal emotional well-being.
